|
CN105175309A
|
|
N-benzyl-5/6-formyl amino indol-2-carboxylic acid derivative and application thereof
|
|
CN105030814A
|
|
Application of polysaccharides
|
|
CN105294610A
|
|
Method for preparing 7-epi-taxane compounds
|
|
CN105037474A
|
|
4'-amino-4'-dehydroxyl-oleandrin and 4'-amino-4'-dehydroxyl-odoroside A and use thereof
|
|
CN104892786A
|
|
Armeniaca mume methyl ester substituted homopolymerized galacturonic acid LEM as well as preparation method and application thereof
|
|
CN104844727A
|
|
Rose acidic pectic polysaccharide and preparation method and application thereof
|
|
CN104840461A
|
|
Use of trans-1-(indole-3-yl)-2-(quinoline-4-yl)-ethylene derivative and composition
|
|
CN104910239A
|
|
Pentacyclic triterpene compound and its preparation method, its pharmaceutical composition and purpose thereof
|
|
CN104910238A
|
|
Pentacyclic triterpene compound and application of pentacyclic triterpene compound in preparation of medicine for treating Alzheimer's disease
|
|
CN104892589A
|
|
Heterocyclic compound, preparation method therefor and use thereof
|
|
CN104407082A
|
|
Method for detecting alkylphenol compounds in ginkgo leaf raw material and preparation
|
|
CN104356038A
|
|
Vitamin D2 and vitamin D3 eutectic crystal as well as preparation method and application thereof
|
|
CN104211942A
|
|
Paclitaxel-block copolymer conjugate, and preparation method and application of paclitaxel-block copolymer conjugate
|
|
CN104069092A
|
|
Use of 2-(substituted phenylamino) benzoic acid and ester compound thereof in preparation of FTO (Fat Mass and Obesity-Associated Protein) inhibitor
|
|
CN105315275A
|
|
Pyrazolone compounds and applications thereof
|
|
CN105218564A
|
|
San Huan oxazolidinone compounds and its production and use
|
|
CN105218356A
|
|
PPAR gamma selective adjusting control agent and its production and use
|
|
CN105272888A
|
|
Bis-arylalkenylalkyl acid compound, and preparation method and application thereof
|
|
CN105294675A
|
|
Preparation method for stepholidine and derivatives thereof
|
|
CN105237440A
|
|
Novel CRAC channel conditioning agent, and preparation method and applications thereof
|
